文献速递新发突发、热带与寄生虫病

扩增子测序作为恶性疟原虫无症状感染中感染复杂性与耐药标志物潜在监测工具

Amplicon Sequencing as a Potential Surveillance Tool for Complexity of Infection and Drug Resistance Markers in Plasmodium falciparum Asymptomatic Infections.
PubMed 文献 · J Infect Dis · 2022-01-01

该研究在肯尼亚沿海地区对无症状疟疾感染及后续首次发热感染进行恶性疟原虫ama1基因扩增子测序,发现超过60%感染为多克隆(感染复杂性COI>1),无症状感染平均COI显著高于发热感染(2.7 vs 2.22),且91%的首次发热感染由新的ama1单倍型引起;mdr1-YY单倍型随时间下降而NY和NF单倍型上升。

要点

  • 无症状感染平均COI为2.7,显著高于发热感染的2.22。
  • 91%的首次发热感染由新的ama1单倍型引起。
  • mdr1-YY单倍型随时间下降,NY和NF单倍型上升。

核心结论

  • 扩增子测序可确定克隆相对比例并检测少数克隆,有助于表征寄生虫多样性,并可用于抗疟药耐药监测。

研究设计与样本

  • 在肯尼亚沿海地区对无症状感染及后续首次发热感染进行恶性疟原虫ama1基因扩增子测序,并分析mdr1单倍型频率的时间变化。

主要发现

  • 超过60%的感染为多克隆(感染复杂性COI>1),且COI随时间下降。
  • 基于ama1序列,无症状感染平均COI为2.7(95%CI 2.65-2.77),发热感染为2.22(95%CI 2.17-2.29),无症状感染显著更高。
  • 30对配对的无症状与首次发热感染分析显示,91%的首次发热感染由新的ama1单倍型引起。
  • 与氯喹和阿莫地喹耐药相关的mdr1-YY单倍型随时间下降,而NY(野生型)和NF(调节对卢美凡特林反应)单倍型上升。

临床怎么用

  • 作者强调扩增子测序可用于表征寄生虫多样性及抗疟药耐药监测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Genotyping Plasmodium falciparum subpopulations in malaria infections is an important aspect of malaria molecular epidemiology to understand within-host diversity and the frequency of drug resistance markers. METHODS: We characterized P. falciparum genetic diversity in asymptomatic infections and subsequent first febrile infections using amplicon sequencing (AmpSeq) of ama1 in Coastal Kenya. We also examined temporal changes in haplotype frequencies of mdr1, a drug-resistant marker. RESULTS: We found >60% of the infections were polyclonal (complexity of infection [COI] >1) and there was a reduction in COI over time. Asymptomatic infections had a significantly higher mean COI than febrile infections based on ama1 sequences (2.7 [95% confidence interval {CI}, 2.65-2.77] vs 2.22 [95% CI, 2.17-2.29], respectively). Moreover, an analysis of 30 paired asymptomatic and first febrile infections revealed that many first febrile infections (91%) were due to the presence of new ama1 haplotypes. The mdr1-YY haplotype, associated with chloroquine and amodiaquine resistance, decreased over time, while the NY (wild type) and the NF (modulates response to lumefantrine) haplotypes increased. CONCLUSIONS: This study emphasizes the utility of AmpSeq in characterizing parasite diversity as it can determine relative proportions of clones and detect minority clones. The usefulness of AmpSeq in antimalarial drug resistance surveillance is also highlighted.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Wamae K, Kimenyi KM, Osoti V, et al. Amplicon Sequencing as a Potential Surveillance Tool for Complexity of Infection and Drug Resistance Markers in Plasmodium falciparum Asymptomatic Infections. J Infect Dis. 2022. PMID: 35429395. doi:10.1093/infdis/jiac144

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。